Request Deal Involvement
Adjuvant Capital, AXA IM and Novo led a $37m Series A round in LimmaTech Biologics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Gorrissen Federspiel
or
Principals
bidder
ADJUVANT CAPITAL
target
LIMMATECH BIOLOGICS
bidder
NOVO HOLDINGS A/S
bidder
AXA INVESTMENT MANAGERS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite